Changes in Pathological Complete Response Rates after Neoadjuvant Chemotherapy for Breast Carcinoma over Five Years

Historically, neoadjuvant chemotherapy (NACT) was extrapolated from adjuvant regimens. Dual HER2 blockade and the introduction of carboplatin for triple negative breast cancers (TNBC) emerged by December 2013 and have improved pathological complete response (pCR) rates. The objective of this study w...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Oncol
Asıl Yazarlar: McFarland, Daniel C., Naikan, Jessica, Rozenblit, Mariya, Mandeli, John, Bleiweiss, Ira, Tiersten, Amy
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi Publishing Corporation 2016
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4921638/
https://ncbi.nlm.nih.gov/pubmed/27382369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/4324863
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller